<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03092141</url>
  </required_header>
  <id_info>
    <org_study_id>MYO-HCFMUSP-04</org_study_id>
    <nct_id>NCT03092141</nct_id>
  </id_info>
  <brief_title>Physical Training in Patients With Relapsing Polychondritis</brief_title>
  <official_title>Physical Training in Patients With Relapsing Polychondritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Physical training may improve physical capacity and health parameters in various systemic
      autoimmune diseases. Therefore, the present study will assess the role of an exercise
      training program in patients with relapsing polychondritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Impact of physical training in patients with relapsing polychondritis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Patients will submitted to physical training (12-weeks, twice/week)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiopulmonary test</measure>
    <time_frame>12 weeks</time_frame>
    <description>Patients will undertake a maximal graded exercise test on a treadmill, with increments in velocity and grade at every minute until volitional exhaustion. VO2peak will be considered as the average of the final 30 s of the test. Ventilatory threshold (VAT) will be determined when ventilatory equivalent for VO2 (VE/VO2) increased without a concomitant increase in ventilatory equivalent for carbon dioxide (VE/VCO2). Respiratory compensation point (RCP) will be determined when VE/VO2 and VE/VCO2 increased simultaneously.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Strength muscle tests</measure>
    <time_frame>12 weeks</time_frame>
    <description>The dynamic 1-RM for the leg-press and the bench-press exercises, arm curl (with the dominant arm), and isometric strength (assessed by handgrip, with the dominant arm) will be assessed at baseline and after the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthy Assessment Questionnaire (HAQ)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Especific questionnaire to assess the quality of life. Pontuaction: 0.00-3.00</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional muscle tests</measure>
    <time_frame>12 weeks</time_frame>
    <description>Muscle function will be evaluated through the TUG and the TST tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle biopsy</measure>
    <time_frame>12 weeks</time_frame>
    <description>After local anesthesia, a cutaneous incision will be made in lateral thigh face. The biopsy will be done using the Bergstrom needle. Histological (hematoxylin and eosin)/immunohistochemical (CD4, CD8, CD68, CD20, C5b-9, MHCI, MHCII, CD31) analysis will be performed in muscle samples (at baseline and after 12 weeks) in all patients (present study)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Physical Activity</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be submitted to physical training (12-weeks, twice/week)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy individuals will be submitted to physical training (12-weeks, twice/week)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical training</intervention_name>
    <arm_group_label>Patients</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Exercises</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fullfill the classification criteria of McADAM et al. (1976)

          -  Using prednisone â‰¤ 0.5 mg/kg/day in the last three months

          -  Sedentary

        Exclusion Criteria:

          -  Disease relapsing

          -  Overlapping disease

          -  Chronic and/or current infections (viral, bacterial or fungal)

          -  Patients undergoing major surgery within six months before the study

          -  With commitment to ambulation (joint affection in limbs)

          -  Smoking

          -  Diabetes mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel K Shinjo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samuel K Shinjo, PhD</last_name>
    <phone>55-11-3061-7176</phone>
    <email>samuel.shinjo@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Samuel Katsuyuki Shinjo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01246903</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel K Shinjo, PhD</last_name>
      <phone>55-3061-7176</phone>
      <email>samuel.shinjo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Diego S Oliveira</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabela BP Borges</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marilda G Silva</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rafael G Misse</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leticia A Perin</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandre M Santos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samara F Alves</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Samuel Katsuyuki Shinjo, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polychondritis, Relapsing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

